
Neil Desai/utswmed.org
Nov 19, 2024, 15:00
NRG-GU010 is approaching the accrual target for the intensification cohort
Nina Niu Sanford, GI Radiation Oncologist at Princeton University, reshared a post by NRG Oncology on X:
“Congrats to study PI Neil Desai!
Prostate coop trials accrue amazingly well. Gotta learn from GU folks.
What is their secret?”
Quoting NRG Oncology‘s post:
“NRG-GU010 is approaching the accrual target for the intensification cohort. Accrual is expected to be complete in about 1-2 weeks.
Please monitor NRG notifications for updates on accrual status.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 16:16
Feb 22, 2025, 16:04
Feb 22, 2025, 16:00
Feb 22, 2025, 15:54
Feb 22, 2025, 15:48
Feb 22, 2025, 15:33
Feb 22, 2025, 15:14
Feb 22, 2025, 15:04
Feb 22, 2025, 14:43
Feb 22, 2025, 14:10
Feb 22, 2025, 13:28
Feb 22, 2025, 13:10